- Home
- IOVA vs MGIC Comparison
IOVA vs MGIC Comparison
Compare IOVA & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- MGIC
- Stock Information
- Founded
- IOVA 2007
- MGIC 1983
- Country
- IOVA United States
- MGIC Israel
- Employees
- IOVA N/A
- MGIC N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- MGIC Computer Software: Prepackaged Software
- Sector
- IOVA Health Care
- MGIC Technology
- Exchange
- IOVA Nasdaq
- MGIC Nasdaq
- Market Cap
- IOVA 975.1M
- MGIC 990.3M
- IPO Year
- IOVA N/A
- MGIC 1991
- Fundamental
- Price
- IOVA $2.18
- MGIC $20.21
- Analyst Decision
- IOVA Buy
- MGIC Buy
- Analyst Count
- IOVA 11
- MGIC 2
- Target Price
- IOVA $11.90
- MGIC $18.00
- AVG Volume (30 Days)
- IOVA 9.8M
- MGIC 37.3K
- Earning Date
- IOVA 11-06-2025
- MGIC 11-17-2025
- Dividend Yield
- IOVA N/A
- MGIC 2.75%
- EPS Growth
- IOVA N/A
- MGIC 16.93
- EPS
- IOVA N/A
- MGIC 0.78
- Revenue
- IOVA $241,525,000.00
- MGIC $584,528,000.00
- Revenue This Year
- IOVA $68.14
- MGIC $11.72
- Revenue Next Year
- IOVA $56.64
- MGIC $6.24
- P/E Ratio
- IOVA N/A
- MGIC $26.41
- Revenue Growth
- IOVA 636.99
- MGIC 11.98
- 52 Week Low
- IOVA $1.64
- MGIC $10.42
- 52 Week High
- IOVA $12.51
- MGIC $22.00
- Technical
- Relative Strength Index (RSI)
- IOVA 46.63
- MGIC 51.41
- Support Level
- IOVA $1.97
- MGIC $19.70
- Resistance Level
- IOVA $2.38
- MGIC $20.98
- Average True Range (ATR)
- IOVA 0.13
- MGIC 0.45
- MACD
- IOVA 0.02
- MGIC 0.08
- Stochastic Oscillator
- IOVA 48.78
- MGIC 53.68
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.